vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
33.50
-0.22 (-0.65%)
At close: May 28, 2026, 4:00 PM EDT
33.50
0.00 (0.00%)
After-hours: May 28, 2026, 4:00 PM EDT
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $419.88 million as of May 28, 2026. Its market cap has increased by 186.71% in one year.
Market Cap
419.88M
Enterprise Value
317.51M
1-Year Change
186.71%
Ranking
Category
Stock Price
$33.50
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $419.88M, an increase of 437.44%. That is a compound annual growth rate of 16.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 418.44M | -15.67% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 440.00M |
| Ovid Therapeutics | 439.51M |
| ADC Therapeutics | 436.27M |
| Monopar Therapeutics | 432.41M |
| Neurogene | 424.60M |
| Prelude Therapeutics | 418.40M |
| Century Therapeutics | 415.72M |
| C4 Therapeutics | 412.08M |